These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 25526480)

  • 21. De novo malignancy in heart transplant recipients: A single center experience in Japan.
    Kimura Y; Yanase M; Mochizuki H; Iwasaki K; Toda K; Matsuda S; Takenaka H; Kumai Y; Kuroda K; Nakajima S; Watanabe T; Ikura MM; Wada K; Matsumoto Y; Seguchi O; Fukushima S; Fujita T; Kobayashi J; Fukushima N
    J Cardiol; 2019 Mar; 73(3):255-261. PubMed ID: 30587457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Temporal Trends of De Novo Malignancy Development After Heart Transplantation.
    Youn JC; Stehlik J; Wilk AR; Cherikh W; Kim IC; Park GH; Lund LH; Eisen HJ; Kim DY; Lee SK; Choi SW; Han S; Ryu KH; Kang SM; Kobashigawa JA
    J Am Coll Cardiol; 2018 Jan; 71(1):40-49. PubMed ID: 29301626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Posttransplant malignancies in solid organ adult recipients: an analysis of the U.S. National Transplant Database.
    Sampaio MS; Cho YW; Qazi Y; Bunnapradist S; Hutchinson IV; Shah T
    Transplantation; 2012 Nov; 94(10):990-8. PubMed ID: 23085553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognosis of Kidney Transplant Recipients With Pretransplantation Malignancy: A Nationwide Population-Based Cohort Study in Taiwan.
    Chiu HF; Chung MC; Chung CJ; Yu TM; Shu KH; Wu MJ
    Transplant Proc; 2016 Apr; 48(3):918-20. PubMed ID: 27234767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival after the diagnosis of de novo malignancy in liver transplant recipients.
    Taborelli M; Piselli P; Ettorre GM; Baccarani U; Burra P; Lauro A; Galatioto L; Rendina M; Shalaby S; Petrara R; Nudo F; Toti L; Fantola G; Cimaglia C; Agresta A; Vennarecci G; Pinna AD; Gruttadauria S; Risaliti A; Di Leo A; Rossi M; Tisone G; Zamboni F; Serraino D;
    Int J Cancer; 2019 Jan; 144(2):232-239. PubMed ID: 30091809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of cyclosporine versus tacrolimus on the incidence of de novo malignancy following liver transplantation: a single center experience with 609 patients.
    Wimmer CD; Angele MK; Schwarz B; Pratschke S; Rentsch M; Khandoga A; Guba M; Jauch KW; Bruns C; Graeb C
    Transpl Int; 2013 Oct; 26(10):999-1006. PubMed ID: 23952102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronologically different incidences of post-transplant malignancies in renal transplant recipients: single center experience.
    Ju MK; Joo DJ; Kim SJ; Huh KH; Kim MS; Jeon KO; Kim HJ; Kim SI; Kim YS
    Transpl Int; 2009 Jun; 22(6):644-53. PubMed ID: 19220824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. De novo cancers following liver transplantation: a single center experience in China.
    Yu S; Gao F; Yu J; Yan S; Wu J; Zhang M; Wang W; Zheng S
    PLoS One; 2014; 9(1):e85651. PubMed ID: 24475047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased risk of post-transplant malignancy and mortality in transplant tourists: a nationwide population-based cohort study in Taiwan.
    Chung MC; Wu MJ; Chang CH; Muo CH; Yu TM; Ho HC; Shu KH; Chung CJ
    Medicine (Baltimore); 2014 Dec; 93(29):e344. PubMed ID: 25546686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Posttransplant malignancies in liver transplant recipients.
    Akdur A; Kırnap M; Yıldırım S; Altundağ Ö; Moray G; Haberal M
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():162-5. PubMed ID: 24635818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. De Novo Malignancies After Liver Transplantation: A Single Institution Experience.
    Egeli T; Unek T; Ozbilgin M; Agalar C; Derici S; Akarsu M; Unek IT; Aysin M; Bacakoglu A; Astarcıoglu I
    Exp Clin Transplant; 2019 Feb; 17(1):74-78. PubMed ID: 29237362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. De novo malignancy after lung transplantation in Japan.
    Miyazaki T; Oto T; Okumura M; Date H; Shiraishi T; Okada Y; Chida M; Kondo T; Nagayasu T
    Gen Thorac Cardiovasc Surg; 2016 Sep; 64(9):543-8. PubMed ID: 27270709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence and risk factors associated with de novo autoimmune hepatitis after liver transplantation.
    Montano-Loza AJ; Vargas-Vorackova F; Ma M; Bain VG; Burak K; Kumar T; Mason AL
    Liver Int; 2012 Oct; 32(9):1426-33. PubMed ID: 22712495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. De novo head and neck cancer arising in solid organ transplantation recipients: The Asan Medical Center experience.
    Park MJ; Roh JL; Choi SH; Nam SY; Kim SY; Lee YS
    Auris Nasus Larynx; 2018 Aug; 45(4):838-845. PubMed ID: 29150348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence of
    Srisuwarn P; Sutharattanapong N; Disthabanchong S; Kantachuvesiri S; Kitiyakara C; Phakdeekitcharoen B; Ingsathit A; Sumethkul V
    Transpl Int; 2024; 37():11614. PubMed ID: 38468637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. De Novo Malignancies After Liver Transplantation With 14 Cases at a Single Center.
    Liu ZN; Wang WT; Yan LN;
    Transplant Proc; 2015 Oct; 47(8):2483-7. PubMed ID: 26518956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review of Standardized Incidence Ratios (SIR) of non-lymphoid de novo malignancies after liver transplantation: Structured analysis of global differences.
    Patel JA; Daoud D; Jain A
    Transplant Rev (Orlando); 2022 Jan; 36(1):100670. PubMed ID: 34688986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation.
    Saigal S; Norris S; Muiesan P; Rela M; Heaton N; O'Grady J
    Liver Transpl; 2002 May; 8(5):482-7. PubMed ID: 12004349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malignancy After Heart Transplantation Under Everolimus Versus Mycophenolate Mofetil Immunosuppression.
    Wang YJ; Chi NH; Chou NK; Huang SC; Wang CH; Wu IH; Yu HY; Chen YS; Tsao CI; Shun CT; Tsai JT; Wang SS
    Transplant Proc; 2016 Apr; 48(3):969-73. PubMed ID: 27234781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. De novo malignancy after liver transplant.
    Sanaei AK; Aliakbarian M; Kazemi K; Nikeghbalian S; Shamsaeefar A; Mehdi SH; Bahreini A; Dehghani SM; Geramizadeh B; Malekhosseini SA
    Exp Clin Transplant; 2015 Apr; 13(2):163-6. PubMed ID: 24844266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.